跳至主要内容
临床试验/RPCEC00000003
RPCEC00000003已完成2 期

Evaluation of the anti oxidating effect of the extract of Mangifera indica L. in people of the third age.

Center of Pharmaceutical Chemistry0 个研究点目标入组 64 人开始时间: 2009年2月27日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Other. Purpose: Prevention

入排标准

年龄范围
60 years 至 one(—)
性别
All

入选标准

  • 1. Persons with 60 year-old or more 2. Written acceptance and voluntary of participating in the clinical trial 3. Good psychological conditions. 4. People that are internal in the Home. 5. Both sexes.

排除标准

  • 1. Infection systemic chronicle. 2. Treatment with anti oxidanting in the last month. 3. Current Hyperbaric Oxygenation or in one period of up to 15 days before the moment of their inclusion. 4. Immunosupresive Therapy or steroids therapy in the moment of their inclusion or in the last 3 months. 5. Renal chronicle or failure or hepatical demonstrated clinically. 6. People with cognitive damage. 7. People with dysphagia. 8. People in period of convalescence (up to two weeks) of a sharp infectious illness that could alter the immune answer. 9. Hypersensibility reaction to the components of the formulation.

研究者

发起方
Center of Pharmaceutical Chemistry

相似试验